IP Library Granted Patent US 8,420,638
Granted Patent B2
US 8,420,638 · App. 13/171,891 · Granted Apr 16, 2013

Triheterocyclic compounds and compositions thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,420,638
App. No.
13/171,891
Granted
Apr 16, 2013
Kind
B2
Abstract

The present invention relates to novel Triheterocyclic Compounds, compositions comprising a Triheterocyclic Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Triheterocyclic Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus.

Claims (6)

1. A composition comprising a pharmaceutically acceptable carrier or vehicle and the compound

or a pharmaceutically acceptable salt thereof.

2. A composition comprising a pharmaceutically acceptable carrier or vehicle and the compound

or a pharmaceutically acceptable salt thereof.

3. A compound selected from

or a pharmaceutically acceptable salt thereof.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jun 5, 2012
From: INVESTISSEMENT QUEBEC
To: GEMIN X PHARMACEUTICALS CANADA INC.
Reel/Frame 028320/0312 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2012
From: ATTARDO, GIORGIO; DAIRI, KENZA; LAVALLEE, JEAN-FRANCOIS; RIOUX, ELISE; TRIPATHY, SASMITA; DOYLE, TERRENCE W; BILLOT, XAVIER
To: GEMIN X BIOTECHNOLOGIES INC.
Reel/Frame 027921/0747 →
CHANGE OF NAME Recorded Mar 23, 2012
From: GEMINX PHARMACEUTICALS CANADA INC.
To: GEMIN X PHARMACEUTICALS CANADA INC.
Reel/Frame 027921/0760 →
CHANGE OF NAME Recorded Mar 23, 2012
From: GEMIN X BIOTECHNOLOGIES INC.
To: GEMINX PHARMACEUTICALS CANADA INC.
Reel/Frame 027921/0763 →